Media Statement Regarding CRE and Duodenoscope

UPDATED 6 p.m. PST Despite the fact that Cedars-Sinai meticulously followed the disinfection procedure for duodenoscopes recommended in instructions provided by the manufacturer (Olympus Corporation) and the FDA, the medical center's infection-control specialists announced today that their investigation has identified a total of four patients who had a CRE transmission (carbapenem-resistant enterobacteriaceae) linked to an ERCP procedure.

March 4, 2015  |  Read Full Story

News Releases

Researchers Advance the Science Behind Treating Patients with Corneal Blindness

January 27, 2015  |  Read Full Story

Nobel Laureate Martin Chalfie to Address International Nanomedicine Conference

January 15, 2015  |  Read Full Story

Neuroscience Critical Care Physician and Researcher Axel Rosengart Joins Cedars-Sinai

January 7, 2015  |  Read Full Story

New Technology Helping Our Smallest Infants Progress Faster in the Neonatal Intensive Care Unit

January 6, 2015  |  Read Full Story

Android app on Google Play